Evidence map›Paper›PMID 25380602›Full record

ArticleJournal of child neurology2015

Neonatal Neurocritical Care Service Is Associated With Decreased Administration of Seizure Medication.

Sharon O Wietstock, Sonia L Bonifacio, Charles E McCulloch, Michael W Kuzniewicz, Hannah C Glass

Abstract read
In one paragraph

Article in Journal of child neurology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Reducing the percentage of surviving infants with acute symptomatic seizures discharged on anti-seizure medication.Journal of perinatology : official journal of the California Perinatal Association · 2025
    Article
  4. Review
  5. Review
  6. Questions and Controversies in Neonatal Seizures.Children (Basel, Switzerland) · 2023
    Review
  7. Review
  8. Continuous electroencephalography in the intensive care unit: A critical review and position statement from an Australian and New Zealand perspective.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine · 2023
    Article
  9. Review
  10. Novel Therapeutics for Neonatal Seizures.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sharon O WietstockDepartments of Pediatrics and Neurology, University of California, San Francisco, CA, USA.
Sonia L BonifacioDepartment of Pediatrics, University of California, San Francisco, CA, USA.
Charles E McCullochDepartment of Epidemiology & Biostatistics, University of California, San Francisco, CA, USA.
Michael W KuzniewiczDepartment of Pediatrics, University of California, San Francisco, CA, USA Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
Hannah C GlassDepartment of Pediatrics, University of California, San Francisco, CA, USA Department of Neurology, University of California, San Francisco, CA, USA Hannah.Glass@ucsf.edu.
University of California, San Francisco · US

Funding

Early Biomarkers in Neonatal Brain InjuryK23NS082500 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BONIFACIO, SONIA L · 2013 to 2017
$977k
MRI Mechanisms of Adverse Outcome in Preterm Infants with SeizuresK23NS066137 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GLASS, HANNAH CRANLEY · 2010 to 2014
$858k
Clinical and Transtional Science InstituteTL1TR000144 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$643k
NCATS NIH HHS TL1 TR000144NCATS NIH HHS TL1TR000144NINDS NIH HHS K23 NS066137NINDS NIH HHS K23NS066137NINDS NIH HHS K23 NS082500NINDS NIH HHS K23NS082500
6 · The paper itself

Abstract

This cohort study examines medication use in term neonates with hypoxic-ischemic encephalopathy and seizures before and after implementation of a Neonatal Neurocritical Care Service (N = 108), which included increased seizure monitoring. Nearly all neonates received phenobarbital (96% pre- vs 95% post-Neonatal Neurocritical Care Service) and total loading dose did not vary among groups (33 [95% confidence interval 29-37] vs 30 [26-34] mg/kg). After adjustment for seizure burden, neonates managed during the Neonatal Neurocritical Care Service era, on average, received 30 mg/kg less cumulative phenobarbital (95% confidence interval 15-46 mg/kg) and were on maintenance 5 fewer days (95% confidence interval 3-8 days) than those who were treated prior to implementation of the service. In spite of the enhanced ability to detect seizures because of improved monitoring and increased vigilance by bedside practitioners, implementation of the Neonatal Neurocritical Care Service was associated with decreased use of potentially harmful phenobarbital treatment among neonates with hypoxic-ischemic encephalopathy.

Indexed as

Intensive Care, NeonatalSeizuresCohort StudiesElectroencephalographyFemaleHumansHypnotics and SedativesHypothermia, InducedHypoxia-Ischemia, BrainMalePhenobarbitalHypnotics and SedativesPhenobarbitalelectroencephalogramepilepsy monitoringhypoxic-ischemic encephalopathyneonatal seizures

Identifiers

PMID25380602
PMCPMC4424192
OpenAlexW1984918698

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.